Publications by authors named "Andre C Schuh"

59Publications

Response Kinetics and Clinical Benefits of Nonintensive AML Therapies in the Absence of Morphologic Response.

Clin Lymphoma Myeloma Leuk 2020 02 26;20(2):e66-e75. Epub 2019 Nov 26.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, Toronto, Canada; Leukemia Program, Department of Medical Oncology and Hematology, University Health Network, Toronto, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2019.11.017DOI Listing
February 2020

Aplastic anaemia in pregnancy - a single centre, North American series.

Br J Haematol 2019 02 20;184(3):436-439. Epub 2018 Nov 20.

Departments of Medicine, Pathology and Laboratory Medicine, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.15654DOI Listing
February 2019

A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.

Support Care Cancer 2019 Jun 19;27(6):2295-2300. Epub 2018 Oct 19.

Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-018-4515-4DOI Listing
June 2019

Time to repeal and replace response criteria for acute myeloid leukemia?

Blood Rev 2018 09 27;32(5):416-425. Epub 2018 Mar 27.

The Alfred Hospital and Monash University, Melbourne, Australia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.blre.2018.03.006DOI Listing
September 2018

Distribution and Impact of Comorbidities on Survival and Leukemic Transformation in Myeloproliferative Neoplasm-Associated Myelofibrosis: A Retrospective Cohort Study.

Clin Lymphoma Myeloma Leuk 2017 11 29;17(11):774-781. Epub 2017 Jun 29.

Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.06.031DOI Listing
November 2017

Azacitidine in adult patients with acute myeloid leukemia.

Crit Rev Oncol Hematol 2017 Aug 3;116:159-177. Epub 2017 Jun 3.

Hôpital Saint Louis, Institut Universitaire d'Hématologie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2017.05.010DOI Listing
August 2017

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

N Engl J Med 2017 03;376(9):836-847

From the Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston (H.K.); City of Hope National Medical Center, Duarte (A.S.), and Amgen, Thousand Oaks (A.F., D.N., Z.Z.) - both in California; Goethe University, University Hospital, Department of Medicine II, Frankfurt am Main (N.G.), Medical Department II (H.-A.H., M.B.) and Hematopathology Section and Lymph Node Registry (W.K.), University Hospital Schleswig Holstein, Campus Kiel, Kiel, and Medizinische Klinik und Poliklinik II, Universitätsklinikums Würzburg, Würzburg (M.S.T.) - all in Germany; Royal Free Hospital and University College London Cancer Institute, London (A.K.F.); Princess Margaret Cancer Centre, Toronto (A.C.S.), and Centre Intégré Universitaire de Santé et de Services Sociaux de l'est de l'île de Montréal, Hôpital Maisonneuve-Rosemont, Montreal (J.B.) - all in Canada; ICO-Hospital Universitari Germans Trias i Pujol, Jose Carreras Research Institute, Universitat Autonoma de Barcelona, Barcelona (J.-M.R.), the Department of Medicine, Hospital Universitari i Politecnic La Fe, University of Valencia, Valencia, and Centro de Investigación Biomédica en Red de Cáncer, Instituto Carlos III, Madrid (M.A.S.) - all in Spain; Alfred Hospital and Monash University, Melbourne, VIC, Australia (A.W.); Institut Universitaire d'Hématologie, Hôpital Saint-Louis (Assistance Publique - Hôpitaux de Paris), Paris (H.D.), and Centre Hospitalier Lyon Sud, Pierre-Benite (X.T.) - both in France; Ematologia, Dipartimento di Biotecnologie Cellulari ed Ematologia, Azienda Ospedaliera Policlinico Umberto I, Università Sapienza di Roma, Rome (R.F.), Azienda Unità Locale Socio Sanitaria 12 Veneziana Ospedale Dell Angelo, Venice (R.B.), and Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Università Statale di Milano, Milan (A.R.) - all in Italy; Ankara Universitesi, Tip Fakültesi, Cebeci Arastirma ve Uygulama Hastanesi, Ankara (Ö.A.), and Dokuz Eylül Üniversitesi Tıp Fakültesi, İzmir (F.D.) - both in Turkey; Instytut Hematologii i Transfuzjologii and Centrum Medyczne Kształcenia Podyplomowego, Warsaw, Poland (E.L.-M.); University of Washington Medical Center, Seattle (B.L.W.); and Amgen, Washington, DC (C.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1609783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5881572PMC
March 2017

Predictive value of molecular remissions postconsolidation chemotherapy in patients with Core Binding Factor Acute Myeloid Leukemia (CBF-AML) - a single center analysis.

Hematol Oncol 2017 Dec 6;35(4):810-813. Epub 2016 Sep 6.

Leukemia Program, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2341DOI Listing
December 2017

A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.

Invest New Drugs 2016 10 12;34(5):614-24. Epub 2016 Jul 12.

Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-016-0375-2DOI Listing
October 2016

Aging, clonal hematopoiesis and preleukemia: not just bad luck?

Int J Hematol 2015 Nov 6;102(5):513-22. Epub 2015 Oct 6.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network (UHN), 610 University Ave, Toronto, ON, M5G 2M9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-015-1870-5DOI Listing
November 2015

Economic evaluation of arsenic trioxide for treatment of newly diagnosed acute promyelocytic leukaemia in Canada.

Hematol Oncol 2015 Dec 25;33(4):229-38. Epub 2014 Nov 25.

Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.2176DOI Listing
December 2015

Salvage induction chemotherapy after azacitdine treatment failure in patients who received azacitidine as a bridge to allogeneic stem cell transplantation.

Br J Haematol 2014 Jul 21;166(2):303-6. Epub 2014 Mar 21.

Division Medical Oncology & Haematology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12844DOI Listing
July 2014

Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen.

Leuk Res 2014 May 5;38(5):532-6. Epub 2013 Nov 5.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.10.025DOI Listing
May 2014

Treatment of elderly patients with acute lymphoblastic leukaemia using a paediatric-based protocol.

Br J Haematol 2013 Nov 13;163(4):458-64. Epub 2013 Sep 13.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12561DOI Listing
November 2013

Treatment of older patients with acute myeloid leukemia (AML): a Canadian consensus.

Am J Blood Res 2013 5;3(2):141-64. Epub 2013 May 5.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre Toronto, Ontario.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649813PMC
May 2013

High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission.

Leuk Res 2013 May 26;37(5):556-60. Epub 2013 Jan 26.

Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2013.01.001DOI Listing
May 2013

Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen.

Leuk Res 2012 Dec 30;36(12):1517-20. Epub 2012 Aug 30.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.08.019DOI Listing
December 2012

Influence of FLT3-internal tandem duplication allele burden and white blood cell count on the outcome in patients with intermediate-risk karyotype acute myeloid leukemia.

Cancer 2012 Dec 26;118(24):6110-7. Epub 2012 Jun 26.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27683
Publisher Site
http://dx.doi.org/10.1002/cncr.27683DOI Listing
December 2012

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocol.

Br J Haematol 2012 Aug 1;158(4):506-14. Epub 2012 Jun 1.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2012.09182.xDOI Listing
August 2012

Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

Am J Hematol 2012 Mar 27;87(3):323-6. Epub 2011 Dec 27.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.22268DOI Listing
March 2012

Improved survival using an intensive, pediatric-based chemotherapy regimen in adults with T-cell acute lymphoblastic leukemia.

Leuk Lymphoma 2010 Jan;51(1):61-5

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903388376DOI Listing
January 2010

Treatment of adults with BCR-ABL negative acute lymphoblastic leukaemia with a modified paediatric regimen.

Br J Haematol 2009 Jun 4;146(1):76-85. Epub 2009 May 4.

Department of Medical Oncology and Haematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07712.xDOI Listing
June 2009

Outcomes of older patients (> or = 60 years) with acquired aplastic anaemia treated with immunosuppressive therapy.

Br J Haematol 2008 Dec;143(5):738-43

Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2008.07389.xDOI Listing
December 2008

Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.

Am J Hematol 2008 Jan;83(1):54-8

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21034DOI Listing
January 2008

Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).

Leuk Lymphoma 2007 Jan;48(1):65-71

Department of Medical Oncology, Peincess Margaret Hospital, University Health Network, Univeristy of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190601043252DOI Listing
January 2007

Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.

J Gene Med 2006 Feb;8(2):129-37

Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jgm.834DOI Listing
February 2006

Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology.

Leuk Res 2006 Feb 25;30(2):233-9. Epub 2005 Jul 25.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, Ont., Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.06.011DOI Listing
February 2006

Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.

J Immunother 2005 Jan-Feb;28(1):28-39

Division of Molecular and Cellular Biology, Research Institute, Sunnybrook and Women's College Health Sciences Center, 2075 Bayview Avenue, Toronto, Canada M4N 3M5.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00002371-200501000-00004DOI Listing
August 2005

Antibody W7C5 defines a CD109 epitope expressed on CD34+ and CD34- hematopoietic and mesenchymal stem cell subsets.

Ann N Y Acad Sci 2003 May;996:227-30

University of Tübingen, Department of Internal Medicine II, Division of Hematology, Immunology, and Oncology, Tübingen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2003.tb03250.xDOI Listing
May 2003

Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice.

Blood 2002 Sep;100(6):2216-24

Division of Molecular and Cellular Biology, Research Institute S-116A, Sunnybrook and Women's College Health Sciences Center, 2075 Bayview Avenue, Toronto, Ontario, Canada M4N 3M5.

View Article

Download full-text PDF

Source
September 2002

A tyrosine703serine polymorphism of CD109 defines the Gov platelet alloantigens.

Blood 2002 Mar;99(5):1692-8

Institute of Medical Science and the Department of Medicine, University of Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.v99.5.1692DOI Listing
March 2002